Breaking News

Lubrizol Unveils $60M Expansion Plan

Will invest in Particle Sciences, Vesta and other facilities in 2017

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lubrizol LifeSciences is spending $60 million on new product solutions, capacity expansion and additional cGMP manufacturing, the company announced. It says these investments will bolster its excipients, polymers, drug formulation and manufacturing, and medical device contract manufacturing capabilities at Lubrizol LifeSciences’ global facilities. Commercial drug product manufacturing will be added at the company’s Particle Sciences facility in Bethlehem, PA. Leveraging the company’s knowledg...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters